iBio, Inc.
IBIO
$1.26
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 100.00K | 300.00K | 300.00K | 500.00K | 400.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 100.00K | 300.00K | 300.00K | 500.00K | 400.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 100.00K | 300.00K | 300.00K | 500.00K | 400.00K |
| SG&A Expenses | 10.60M | 14.95M | 12.81M | 10.39M | 10.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.24M | 29.26M | 25.77M | 20.95M | 19.00M |
| Operating Income | -30.14M | -28.96M | -25.47M | -20.45M | -18.60M |
| Income Before Tax | -33.04M | -27.61M | -24.74M | -20.11M | -18.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -33.04 | -27.61 | -24.74 | -20.11 | -18.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.04M | -27.61M | -24.74M | -20.11M | -18.38M |
| EBIT | -30.14M | -28.96M | -25.47M | -20.45M | -18.60M |
| EBITDA | -29.49M | -28.27M | -24.74M | -19.67M | -17.83M |
| EPS Basic | -0.52 | -0.81 | -1.23 | -1.62 | -1.79 |
| Normalized Basic EPS | -0.30 | -0.50 | -0.77 | -1.01 | -1.12 |
| EPS Diluted | -0.52 | -0.81 | -1.23 | -1.62 | -1.79 |
| Normalized Diluted EPS | -0.30 | -0.50 | -0.77 | -1.01 | -1.12 |
| Average Basic Shares Outstanding | 383.75M | 252.79M | 143.05M | 53.05M | 42.02M |
| Average Diluted Shares Outstanding | 383.75M | 252.79M | 143.05M | 53.05M | 42.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |